Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromuscular Block and Anesthetic Depth Monitoring
NCT02575443Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rocuronium in gallbladder disease (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Total infused dose of propofol. Started Sep 2015; status: completed.
02
Drugs
rocuronium
03
Conditions
gallbladder disease
Beyond the preview
Go deeper on NCT02575443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575443.